Updated Jul 16, 2026
Tactic Pharma LLC is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $36.17M.

| Role | 10% Owner |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-09-24 | MNPR | Monopar Therapeutics | S — Open-market sale | 550.2K | $63.61 | $35.00M |
| 2025-04-02 | MNPR | Monopar Therapeutics | S — Open-market sale | 33.3K | $35.00 | $1.17M |
Tactic Pharma LLC is a corporate insider — currently tracked as 10% Owner. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($36.17M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Tactic Pharma LLC profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.